Journal profile · Toxicology
Xenobiotica
ISSN 0049-8254 · eISSN 1366-5928 · Informa Healthcare · ENGLAND · Monthly · Founded 1971
Xenobiotica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.52; subscription journal; median 78 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 77 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Xenobiotica is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Drug-Induced Hepatotoxicity and Protection, together about 50.1% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology
Source: LetPub
Research area (LetPub): Toxicology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics26.3%
- Drug Transport and Resistance MechanismsMedicine17.5%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics6.3%
- Eicosanoids and Hypertension PharmacologyBiochemistry, Genetics and Molecular Biology4.3%
- Pharmacological Effects and Toxicity StudiesMedicine4%
- Analytical Chemistry and ChromatographyChemistry3.9%
- Antibiotics Pharmacokinetics and EfficacyMedicine3.6%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.52LetPub ·
- CiteScore 2026-06
- 2.5LetPub ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.46LetPub ·
- h-index
- 75LetPub ·
- h-index
- 118OpenAlex ·
- i10-index
- 3,281OpenAlex ·
- 2-year mean citedness
- 1.9OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4.44%LetPub ·
Volume
- Articles per year
- 74LetPub ·
Articles by year OpenAlex count · 5,889 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 65 | 13 | 19 |
| 2025 | 77 | 8 | 122 |
| 2024 | 77 | 29 | 275 |
| 2023 | 73 | 26 | 325 |
| 2022 | 100 | 43 | 512 |
| 2021 | 108 | 38 | 701 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
78 daysMedian, submission to acceptance · P25–P75 59 days – 115 days
- Acceptance to online
- median 17 days (97 articles)
- Submission to online
- median 95 days
- Sample
- 97 articles with submission and acceptance dates (155 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1971
- ISSN
- 0049-8254
- Electronic ISSN
- 1366-5928
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Xenobiotica
What CAS zone is Xenobiotica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Xenobiotica is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy / Toxicology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Xenobiotica?
The latest impact factor listed by LetPub is 1.52; CiteScore 2.5, h-index 118.
How long does peer review take at Xenobiotica?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 59–115 days); authors report an average review time of about 2 months; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Xenobiotica?
According to LetPub and DOAJ records, Xenobiotica is indexed in SCIE and Scopus.
Is Xenobiotica open access, and what is the APC?
Xenobiotica is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .